HOME SUBSCRIPTIONS CURRENT ISSUE PAST ISSUES CARDIOSOURCE SEARCH HELP FEEDBACK		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Related articles in JACC Similar articles in this journal Similar articles in ISI Web of Science Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (1) Google Scholar Articles by Russo, A. Articles by Enriquez-Sarano, M. PubMed Articles by Russo, A. Articles by Enriquez-Sarano, M.

CLINICAL RESEARCH: MITRAL SURGERY AND EMBOLISM

Thromboembolic Complications After Surgical Correction of Mitral Regurgitation

Incidence, Predictors, and Clinical Implications

Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic College of Medicine, Rochester, Minnesota.

Manuscript received May 1, 2007; revised manuscript received September 24, 2007, accepted October 1, 2007.

^_* Reprint requests and correspondence: Dr. Maurice Enriquez-Sarano, Mayo Clinic, 200 First Street SW, Rochester, Minnesota 55905. (Email: sarano.maurice{at}mayo.edu).

Objectives: We sought to define thromboembolic risk after surgery for mitral regurgitation (MR), particularly ischemic stroke (IS) compared with the general population.

Background: Guidelines recommend surgery in asymptomatic patients with MR, but IS risks are unknown.

Methods: In 1,344 patients (age 65 ± 12 years) consecutively operated for MR (procedures: 897 mitral valve repair [MRep] and 447 valve replacement: 231 mechanical mitral valve replacement [MVRm], 216 biological mitral valve replacement [MVRb]), thromboembolic complications, particularly IS (diagnosed by neurologists), during follow-up were assessed early (<30 days), midterm (30 to 180 days), and long-term (180 days).

Results: Ischemic stroke occurred in 130 patients: 1.9 ± 0.4% and 2.7 ± 0.5% at 30 days and 180 days, respectively, and 8.1 ± 0.8% at 5 years. We found that IS rates were lowest after MRep versus MVRb and MVRm (6.1 ± 0.9% vs. 8 ± 2.1%, and 16.1 ± 2.7% at 5 years, respectively, p < 0.001). Comparison with population-expected IS showed high risk at <30 days (risk ratio 41, 95% confidence interval 26 to 60, p < 0.001 but p > 0.10 between procedures) and moderate risk at >30 days (risk ratio 1.7 overall; 1.3 for MRep; 0.98 for MVRb; 4.8 for MVRm). Beyond 180 days, IS risk declined further and was similar to the population for MRep (relative risk 1.2) and for MVRb (relative risk 0.9). Bleeding risk >30 days was lowest in MRep versus MVRb and MVRm (10-year risk 7 ± 1%, 14 ± 4%, and 16 ± 3%, respectively).

Conclusions: Thromboembolic complications after MR surgery are a reason for both concern and encouragement. The risk of IS is notable early, irrespective of procedure, but in the long term it is not greater than in the population after MRep and MVRb. Preference for MRep should be emphasized, and trials aiming at preventing IS should be conducted to reduce thromboembolic and hemorrhagic risk after surgery for MR.

Abbreviations and Acronyms   AF = atrial fibrillation   CABG = coronary artery bypass grafting   ICH = intracranial hemorrhage   IS = ischemic stroke   MR = mitral regurgitation   MRep = mitral valve repair   MVR = mitral valve replacement   RR = risk ratio   TE = thromboembolic event   TIA = transient ischemic attack

Related articles in JACC:

Thromboembolic Complications After Surgical Correction of Mitral Regurgitation: Finding a Balance

Robert A. Dion
JACC 2008 51: 1212-1213. [Full Text]  

Inside This Issue of JACC

JACC 2008 51: A31-A32. [Full Text]  

This article has been cited by other articles:

				R. A. Dion Thromboembolic Complications After Surgical Correction of Mitral Regurgitation: Finding a Balance J. Am. Coll. Cardiol., March 25, 2008; 51(12): 1212 - 1213. [Full Text] [PDF]